Skip to content

Sigilon Therapeutics, Inc.

Delisted

CIK 1821323fmd_15HWNDBHSJD2ZWEP8S3XGVS63JManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2020 to Jun 30, 2023, 14 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading